Company Description

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.

Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial.

The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Bio Green Med Solution, Inc.

Country	Malaysia
Founded	1996
Employees	12
CEO	Sing Wong

Contact Details

Address: Level 10, Tower 11 Kuala Lumpur, 592000 Malaysia
Phone	60 9 08517 7330
Website	cyclacel.com

Stock Details

Ticker Symbol	BGMS
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD

Key Executives

Name	Position
Sing Wong	Chief Executive Officer
Cu Kiu	Chief Financial Officer